Browse By

Daily Archives: November 25, 2019

FDA Warns 15 Companies for Illegally Selling Various Products Containing Cannabidiol (CBD) as Agency Details Safety Concerns

For Immediate Release:November 25, 2019 Today, the U.S. Food and Drug Administration issued warning letters to 15 companies for illegally selling products containing cannabidiol (CBD) in ways that violate the Federal Food, Drug, and Cosmetic Act (FD&C Act). The FDA also published a revised Consumer Update detailing

JanOne Soars 55% Acquires Worldwide, Exclusive License for Promising Treatment of Peripheral Arterial Disease (PAD)

Phase 2b testing planned for PAD treatment and PAD-associated pain to address 8.5 million patient US market LAS VEGAS, Nov. 25, 2019 /PRNewswire/ — JanOne Inc. (NASDAQ: JAN), a company focused on reducing opioid addiction by finding treatments for conditions accompanied by pain and bringing to market drugs and

GrowGeneration Corp. Approved to Begin Trading on NASDAQ Stock Exchange

DENVER, Nov. 25, 2019 /PRNewswire/ – GrowGeneration Corp. (NASDAQ: GRWG), (“GrowGen” or the “Company”) the largest chain of specialty retail hydroponic and organic garden centers, with currently 25 locations, is pleased to announce that its common shares have been approved for listing on the Nasdaq Capital Market (“NASDAQ”). GrowGeneration Corp.

FDA Approves Advancement of PPP001 Clinical Trial Previously Discontinued

Company to resume clinical trial in advanced cancer patients with uncontrolled pain Tetra engages leading clinical collaborator to run Plenitude trial in the U.S. OTTAWA, Nov. 25, 2019 (GLOBE NEWSWIRE) — Tetra Bio-Pharma Inc., (TSX-V: TBP) (OTCQB: TBPMF), a leader in drug discovery and development for cannabinoid-based therapeutics,

INVICTUS CLOSES TERMINATION OF AUTHENTIC BRANDS GROUP LICENSE AGREEMENT

Vancouver, B.C., Nov. 25, 2019 (GLOBE NEWSWIRE) — INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) the Company is pleased to announce the completion, effective September 30, 2019, of the previously announced termination of its license agreement with ABG-HMX, LLC

MJardin Group Announces Third Quarter 2019 Financial Results

DENVER and TORONTO, Nov. 25, 2019 (GLOBE NEWSWIRE) — MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, today announced its financial and operating results for the three and nine-month periods ending September 30, 2019. All amounts are

Sorrento Therapeutics, Inc. Received and Rejected Unsolicited All Cash Acquisition Proposal, Stock Price Soars 30% Pre- Market

November 25, 2019 07:00 ET | Source: Sorrento Therapeutics, SAN DIEGO, Nov. 25, 2019 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (NASDAQ: SRNE, “Sorrento” or the “Company”), confirmed today that on November 23, 2019, it received an unsolicited, non-binding term sheet proposal submitted by two biopharmaceutical companies, to acquire